Linking hypoxia, DNA damage and proliferation in multicellular tumor spheroids

BMC Cancer
Stephen RiffleRashmi S Hegde

Abstract

Multicellular Tumor Spheroids are frequently used to mimic the regionalization of proliferation and the hypoxic environment within avascular tumors. Here we exploit these features to study the activation of DNA damage repair pathways and their correlation to developing hypoxia. Activation of DNA damage repair markers, proliferation, cell death, glycogen accumulation and developing hypoxia were investigated using immunofluorescence, immuno-histochemistry, EdU incorporation, Western blots, COMET assays, and pharmacological agents in A673 Ewing sarcoma spheroids and monolayer cultures. DNA damage marker γ-H2AX is observed in the hypoxic, peri-necrotic region of growing spheroids. While most proliferating cells are seen on the spheroid surface, there are also a few Ki-67 positive cells in the hypoxic zone. The hypoxia-induced phosphorylation of H2AX to form γ-H2AX in spheroids is attenuated by the ATM inhibitor KU55933, but not the ATR inhibitor VE-821. Tumor spheroids mimic tumor microenvironments such as the anoxic, hypoxic and oxic niches within solid tumors, as well as populations of cells that are viable, proliferating, and undergoing DNA damage repair processes under these different micro-environmental conditions. ATM, but no...Continue Reading

References

May 16, 1995·International Journal of Cancer. Journal International Du Cancer·M W GrossW Mueller-Klieser
Feb 28, 2002·Molecular and Cellular Biology·Ester M HammondAmato J Giaccia
Jan 10, 2003·The Journal of Biological Chemistry·Ester M HammondAmato J Giaccia
Jul 29, 2004·DNA Repair·Ester M Hammond, Amato J Giaccia
Apr 7, 2007·Cancer Metastasis Reviews·Ranjit S BindraPeter M Glazer
Jul 25, 2008·Nature Reviews. Cancer·Gabriele Bergers, Douglas Hanahan
Nov 5, 2008·Molecular and Cellular Biology·Zuzana BencokovaEster M Hammond
Apr 21, 2009·Nature Medicine·Matina EconomopoulouTriantafyllos Chavakis
May 30, 2009·Cancer Cell·Erinn B RankinEster M Hammond
Jan 28, 2010·Cancer Research·Isabel M PiresEster M Hammond
Mar 31, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sebastien de FeraudyJames E Cleaver
Sep 30, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monica OlcinaEster M Hammond
Apr 15, 2011·Nature Chemical Biology·Philip M ReaperJohn R Pollard
Jun 28, 2011·The Journal of Biological Chemistry·Edward A NamDavid Cortez
Jul 23, 2011·Molecular Cell·Shizhou LiuLee Zou
Jun 21, 2012·British Journal of Cancer·I M PiresE M Hammond
Jul 14, 2012·Expert Opinion on Drug Discovery·Daniel V LaBarberaByong Hoon Yoo
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Feb 12, 2013·BMC Cancer·Jennifer LaurentValérie Lobjois
Aug 7, 2013·Mutation Research·Ralph Scully, Anyong Xie
Nov 26, 2013·Molecular Cell·Monica M OlcinaEster M Hammond
Jan 17, 2014·Journal of the Royal Society, Interface·David Robert GrimesMike Partridge
Mar 14, 2014·Redox Biology·Benjamin M GyoriMarie-Veronique Clement
May 10, 2015·DNA Repair·Susan E Scanlon, Peter M Glazer
Jan 15, 2016·The American Journal of Pathology·Yuhua WangRashmi S Hegde
Feb 18, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Christos E Zois, Adrian L Harris
Jan 1, 2014·Molecular & Cellular Oncology·Monica M OlcinaEster M Hammond
Sep 1, 2016·Oncotarget·Maria Nieto-SolerOscar Fernandez-Capetillo

❮ Previous
Next ❯

Citations

Nov 6, 2018·Oncogene·Adi Karsch-BlumanOfra Benny
Jun 18, 2019·Pediatric Blood & Cancer·Antonio Romo-MoralesJanet M Shipley
Jul 12, 2019·Journal of Cancer Research and Clinical Oncology·Clarissa WillersChrisna Gouws
Aug 5, 2017·Journal of Experimental & Clinical Cancer Research : CR·Stephen Riffle, Rashmi S Hegde
May 5, 2020·Expert Opinion on Drug Discovery·Blaise Calpe, Werner J Kovacs
Jul 31, 2020·Critical Reviews in Biochemistry and Molecular Biology·Rashmi S HegdeRam Naresh Pandey
Feb 19, 2020·Current Pharmaceutical Design·Eleonore Fröhlich
Aug 31, 2020·Cell Death Discovery·Katheryn Begg, Mahvash Tavassoli
Nov 24, 2018·Frontiers in Immunology·Andrea M ChambersSandro Matosevic
Jul 18, 2020·Journal of Hematology & Oncology·Michele ZanoniAnna Tesei
Feb 3, 2021·Cancers·Tord HomplandHeidi Lyng
Feb 1, 2021·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Maeva BavouxPhilip Wong
Feb 11, 2021·Cell Death Discovery·Katheryn Begg, Mahvash Tavassoli
Jun 23, 2021·Acta histochemica·Eda AcikgozMustafa Guven
Jul 10, 2021·Frontiers in Bioengineering and Biotechnology·Gabriela S KronembergerLeandra S Baptista
Jul 27, 2021·Journal of Bone Oncology·Javier Munoz-GarciaDominique Heymann
Jul 31, 2021·Nature Biomedical Engineering·Tiffany ChienTal Danino
Aug 3, 2021·Expert Review of Molecular Diagnostics·Narges DastmalchiShahram Teimourian
Jan 19, 2021·ACS Biomaterials Science & Engineering·Hao-Fei WangChun-Xia Zhao
Sep 4, 2021·Analytical Chemistry·Robert KnitschRoland Hergenröder
Oct 7, 2021·Environmental Science and Pollution Research International·Smita KumariRashmi K Ambasta

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
light microscopy
xenografts

Software Mentioned

OpenCOMET
ImageJ
MCTS
Graphpad PRISM

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.